Global Molecular Diagnosis of Rectal Cancer Market Insights, Forecast to 2029
This report presents an overview of global market for Molecular Diagnosis of Rectal Cancer market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Molecular Diagnosis of Rectal Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Molecular Diagnosis of Rectal Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Molecular Diagnosis of Rectal Cancer revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Molecular Diagnosis of Rectal Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Molecular Diagnosis of Rectal Cancer revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Kingmed, Geneis, Unitedgene, Yin Feng Gene, Inmedi, Amoydx, Genetronhealth, Berryoncology and Topgen, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Molecular Diagnosis of Rectal Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnosis of Rectal Cancer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Diagnosis of Rectal Cancer revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Molecular Diagnosis of Rectal Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Molecular Diagnosis of Rectal Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Molecular Diagnosis of Rectal Cancer revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Molecular Diagnosis of Rectal Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Molecular Diagnosis of Rectal Cancer revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Kingmed, Geneis, Unitedgene, Yin Feng Gene, Inmedi, Amoydx, Genetronhealth, Berryoncology and Topgen, etc.
By Company
- Kingmed
- Geneis
- Unitedgene
- Yin Feng Gene
- Inmedi
- Amoydx
- Genetronhealth
- Berryoncology
- Topgen
- Roche
- Qiagen
- PCR
- FISH
- DNA Sequencing
- Gene Chip
- Clinical Diagnosis
- Drug Screening
- Research
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Molecular Diagnosis of Rectal Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnosis of Rectal Cancer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Diagnosis of Rectal Cancer revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Molecular Diagnosis of Rectal Cancer Market Perspective (2018-2029)
2.2 Global Molecular Diagnosis of Rectal Cancer Growth Trends by Region
2.2.1 Molecular Diagnosis of Rectal Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Molecular Diagnosis of Rectal Cancer Historic Market Size by Region (2018-2023)
2.2.3 Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Region (2024-2029)
2.3 Molecular Diagnosis of Rectal Cancer Market Dynamics
2.3.1 Molecular Diagnosis of Rectal Cancer Industry Trends
2.3.2 Molecular Diagnosis of Rectal Cancer Market Drivers
2.3.3 Molecular Diagnosis of Rectal Cancer Market Challenges
2.3.4 Molecular Diagnosis of Rectal Cancer Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Molecular Diagnosis of Rectal Cancer by Players
3.1.1 Global Molecular Diagnosis of Rectal Cancer Revenue by Players (2018-2023)
3.1.2 Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnosis of Rectal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Molecular Diagnosis of Rectal Cancer, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Molecular Diagnosis of Rectal Cancer Market Concentration Ratio
3.4.1 Global Molecular Diagnosis of Rectal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis of Rectal Cancer Revenue in 2022
3.5 Global Key Players of Molecular Diagnosis of Rectal Cancer Head office and Area Served
3.6 Global Key Players of Molecular Diagnosis of Rectal Cancer, Product and Application
3.7 Global Key Players of Molecular Diagnosis of Rectal Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 MOLECULAR DIAGNOSIS OF RECTAL CANCER BREAKDOWN DATA BY TYPE
4.1 Global Molecular Diagnosis of Rectal Cancer Historic Market Size by Type (2018-2023)
4.2 Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Type (2024-2029)
5 MOLECULAR DIAGNOSIS OF RECTAL CANCER BREAKDOWN DATA BY APPLICATION
5.1 Global Molecular Diagnosis of Rectal Cancer Historic Market Size by Application (2018-2023)
5.2 Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Molecular Diagnosis of Rectal Cancer Market Size (2018-2029)
6.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Type
6.2.1 North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023)
6.2.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029)
6.2.3 North America Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
6.3 North America Molecular Diagnosis of Rectal Cancer Market Size by Application
6.3.1 North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023)
6.3.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029)
6.3.3 North America Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
6.4 North America Molecular Diagnosis of Rectal Cancer Market Size by Country
6.4.1 North America Molecular Diagnosis of Rectal Cancer Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023)
6.4.3 North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Molecular Diagnosis of Rectal Cancer Market Size (2018-2029)
7.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Type
7.2.1 Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023)
7.2.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029)
7.2.3 Europe Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
7.3 Europe Molecular Diagnosis of Rectal Cancer Market Size by Application
7.3.1 Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023)
7.3.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029)
7.3.3 Europe Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
7.4 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country
7.4.1 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023)
7.4.3 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Molecular Diagnosis of Rectal Cancer Market Size (2018-2029)
8.2 China Molecular Diagnosis of Rectal Cancer Market Size by Type
8.2.1 China Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023)
8.2.2 China Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029)
8.2.3 China Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
8.3 China Molecular Diagnosis of Rectal Cancer Market Size by Application
8.3.1 China Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023)
8.3.2 China Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029)
8.3.3 China Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Molecular Diagnosis of Rectal Cancer Market Size (2018-2029)
9.2 Asia Molecular Diagnosis of Rectal Cancer Market Size by Type
9.2.1 Asia Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023)
9.2.2 Asia Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029)
9.2.3 Asia Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
9.3 Asia Molecular Diagnosis of Rectal Cancer Market Size by Application
9.3.1 Asia Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023)
9.3.2 Asia Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029)
9.3.3 Asia Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
9.4 Asia Molecular Diagnosis of Rectal Cancer Market Size by Region
9.4.1 Asia Molecular Diagnosis of Rectal Cancer Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Molecular Diagnosis of Rectal Cancer Market Size by Region (2018-2023)
9.4.3 Asia Molecular Diagnosis of Rectal Cancer Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type
10.2.1 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application
10.3.1 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country
10.4.1 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Kingmed
11.1.1 Kingmed Company Details
11.1.2 Kingmed Business Overview
11.1.3 Kingmed Molecular Diagnosis of Rectal Cancer Introduction
11.1.4 Kingmed Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.1.5 Kingmed Recent Developments
11.2 Geneis
11.2.1 Geneis Company Details
11.2.2 Geneis Business Overview
11.2.3 Geneis Molecular Diagnosis of Rectal Cancer Introduction
11.2.4 Geneis Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.2.5 Geneis Recent Developments
11.3 Unitedgene
11.3.1 Unitedgene Company Details
11.3.2 Unitedgene Business Overview
11.3.3 Unitedgene Molecular Diagnosis of Rectal Cancer Introduction
11.3.4 Unitedgene Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.3.5 Unitedgene Recent Developments
11.4 Yin Feng Gene
11.4.1 Yin Feng Gene Company Details
11.4.2 Yin Feng Gene Business Overview
11.4.3 Yin Feng Gene Molecular Diagnosis of Rectal Cancer Introduction
11.4.4 Yin Feng Gene Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.4.5 Yin Feng Gene Recent Developments
11.5 Inmedi
11.5.1 Inmedi Company Details
11.5.2 Inmedi Business Overview
11.5.3 Inmedi Molecular Diagnosis of Rectal Cancer Introduction
11.5.4 Inmedi Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.5.5 Inmedi Recent Developments
11.6 Amoydx
11.6.1 Amoydx Company Details
11.6.2 Amoydx Business Overview
11.6.3 Amoydx Molecular Diagnosis of Rectal Cancer Introduction
11.6.4 Amoydx Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.6.5 Amoydx Recent Developments
11.7 Genetronhealth
11.7.1 Genetronhealth Company Details
11.7.2 Genetronhealth Business Overview
11.7.3 Genetronhealth Molecular Diagnosis of Rectal Cancer Introduction
11.7.4 Genetronhealth Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.7.5 Genetronhealth Recent Developments
11.8 Berryoncology
11.8.1 Berryoncology Company Details
11.8.2 Berryoncology Business Overview
11.8.3 Berryoncology Molecular Diagnosis of Rectal Cancer Introduction
11.8.4 Berryoncology Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.8.5 Berryoncology Recent Developments
11.9 Topgen
11.9.1 Topgen Company Details
11.9.2 Topgen Business Overview
11.9.3 Topgen Molecular Diagnosis of Rectal Cancer Introduction
11.9.4 Topgen Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.9.5 Topgen Recent Developments
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Molecular Diagnosis of Rectal Cancer Introduction
11.10.4 Roche Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.10.5 Roche Recent Developments
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Molecular Diagnosis of Rectal Cancer Introduction
11.11.4 Qiagen Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.11.5 Qiagen Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Molecular Diagnosis of Rectal Cancer Market Perspective (2018-2029)
2.2 Global Molecular Diagnosis of Rectal Cancer Growth Trends by Region
2.2.1 Molecular Diagnosis of Rectal Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Molecular Diagnosis of Rectal Cancer Historic Market Size by Region (2018-2023)
2.2.3 Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Region (2024-2029)
2.3 Molecular Diagnosis of Rectal Cancer Market Dynamics
2.3.1 Molecular Diagnosis of Rectal Cancer Industry Trends
2.3.2 Molecular Diagnosis of Rectal Cancer Market Drivers
2.3.3 Molecular Diagnosis of Rectal Cancer Market Challenges
2.3.4 Molecular Diagnosis of Rectal Cancer Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Molecular Diagnosis of Rectal Cancer by Players
3.1.1 Global Molecular Diagnosis of Rectal Cancer Revenue by Players (2018-2023)
3.1.2 Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnosis of Rectal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Molecular Diagnosis of Rectal Cancer, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Molecular Diagnosis of Rectal Cancer Market Concentration Ratio
3.4.1 Global Molecular Diagnosis of Rectal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis of Rectal Cancer Revenue in 2022
3.5 Global Key Players of Molecular Diagnosis of Rectal Cancer Head office and Area Served
3.6 Global Key Players of Molecular Diagnosis of Rectal Cancer, Product and Application
3.7 Global Key Players of Molecular Diagnosis of Rectal Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 MOLECULAR DIAGNOSIS OF RECTAL CANCER BREAKDOWN DATA BY TYPE
4.1 Global Molecular Diagnosis of Rectal Cancer Historic Market Size by Type (2018-2023)
4.2 Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Type (2024-2029)
5 MOLECULAR DIAGNOSIS OF RECTAL CANCER BREAKDOWN DATA BY APPLICATION
5.1 Global Molecular Diagnosis of Rectal Cancer Historic Market Size by Application (2018-2023)
5.2 Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Molecular Diagnosis of Rectal Cancer Market Size (2018-2029)
6.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Type
6.2.1 North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023)
6.2.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029)
6.2.3 North America Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
6.3 North America Molecular Diagnosis of Rectal Cancer Market Size by Application
6.3.1 North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023)
6.3.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029)
6.3.3 North America Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
6.4 North America Molecular Diagnosis of Rectal Cancer Market Size by Country
6.4.1 North America Molecular Diagnosis of Rectal Cancer Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023)
6.4.3 North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Molecular Diagnosis of Rectal Cancer Market Size (2018-2029)
7.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Type
7.2.1 Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023)
7.2.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029)
7.2.3 Europe Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
7.3 Europe Molecular Diagnosis of Rectal Cancer Market Size by Application
7.3.1 Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023)
7.3.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029)
7.3.3 Europe Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
7.4 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country
7.4.1 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023)
7.4.3 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Molecular Diagnosis of Rectal Cancer Market Size (2018-2029)
8.2 China Molecular Diagnosis of Rectal Cancer Market Size by Type
8.2.1 China Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023)
8.2.2 China Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029)
8.2.3 China Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
8.3 China Molecular Diagnosis of Rectal Cancer Market Size by Application
8.3.1 China Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023)
8.3.2 China Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029)
8.3.3 China Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Molecular Diagnosis of Rectal Cancer Market Size (2018-2029)
9.2 Asia Molecular Diagnosis of Rectal Cancer Market Size by Type
9.2.1 Asia Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023)
9.2.2 Asia Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029)
9.2.3 Asia Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
9.3 Asia Molecular Diagnosis of Rectal Cancer Market Size by Application
9.3.1 Asia Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023)
9.3.2 Asia Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029)
9.3.3 Asia Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
9.4 Asia Molecular Diagnosis of Rectal Cancer Market Size by Region
9.4.1 Asia Molecular Diagnosis of Rectal Cancer Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Molecular Diagnosis of Rectal Cancer Market Size by Region (2018-2023)
9.4.3 Asia Molecular Diagnosis of Rectal Cancer Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type
10.2.1 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application
10.3.1 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country
10.4.1 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Kingmed
11.1.1 Kingmed Company Details
11.1.2 Kingmed Business Overview
11.1.3 Kingmed Molecular Diagnosis of Rectal Cancer Introduction
11.1.4 Kingmed Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.1.5 Kingmed Recent Developments
11.2 Geneis
11.2.1 Geneis Company Details
11.2.2 Geneis Business Overview
11.2.3 Geneis Molecular Diagnosis of Rectal Cancer Introduction
11.2.4 Geneis Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.2.5 Geneis Recent Developments
11.3 Unitedgene
11.3.1 Unitedgene Company Details
11.3.2 Unitedgene Business Overview
11.3.3 Unitedgene Molecular Diagnosis of Rectal Cancer Introduction
11.3.4 Unitedgene Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.3.5 Unitedgene Recent Developments
11.4 Yin Feng Gene
11.4.1 Yin Feng Gene Company Details
11.4.2 Yin Feng Gene Business Overview
11.4.3 Yin Feng Gene Molecular Diagnosis of Rectal Cancer Introduction
11.4.4 Yin Feng Gene Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.4.5 Yin Feng Gene Recent Developments
11.5 Inmedi
11.5.1 Inmedi Company Details
11.5.2 Inmedi Business Overview
11.5.3 Inmedi Molecular Diagnosis of Rectal Cancer Introduction
11.5.4 Inmedi Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.5.5 Inmedi Recent Developments
11.6 Amoydx
11.6.1 Amoydx Company Details
11.6.2 Amoydx Business Overview
11.6.3 Amoydx Molecular Diagnosis of Rectal Cancer Introduction
11.6.4 Amoydx Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.6.5 Amoydx Recent Developments
11.7 Genetronhealth
11.7.1 Genetronhealth Company Details
11.7.2 Genetronhealth Business Overview
11.7.3 Genetronhealth Molecular Diagnosis of Rectal Cancer Introduction
11.7.4 Genetronhealth Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.7.5 Genetronhealth Recent Developments
11.8 Berryoncology
11.8.1 Berryoncology Company Details
11.8.2 Berryoncology Business Overview
11.8.3 Berryoncology Molecular Diagnosis of Rectal Cancer Introduction
11.8.4 Berryoncology Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.8.5 Berryoncology Recent Developments
11.9 Topgen
11.9.1 Topgen Company Details
11.9.2 Topgen Business Overview
11.9.3 Topgen Molecular Diagnosis of Rectal Cancer Introduction
11.9.4 Topgen Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.9.5 Topgen Recent Developments
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Molecular Diagnosis of Rectal Cancer Introduction
11.10.4 Roche Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.10.5 Roche Recent Developments
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Molecular Diagnosis of Rectal Cancer Introduction
11.11.4 Qiagen Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
11.11.5 Qiagen Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Molecular Diagnosis of Rectal Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Molecular Diagnosis of Rectal Cancer Market Share by Region (2018-2023)
Table 10. Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Molecular Diagnosis of Rectal Cancer Market Share by Region (2024-2029)
Table 12. Molecular Diagnosis of Rectal Cancer Market Trends
Table 13. Molecular Diagnosis of Rectal Cancer Market Drivers
Table 14. Molecular Diagnosis of Rectal Cancer Market Challenges
Table 15. Molecular Diagnosis of Rectal Cancer Market Restraints
Table 16. Global Molecular Diagnosis of Rectal Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Molecular Diagnosis of Rectal Cancer Revenue Share by Players (2018-2023)
Table 18. Global Top Molecular Diagnosis of Rectal Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Rectal Cancer as of 2022)
Table 19. Global Molecular Diagnosis of Rectal Cancer Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Molecular Diagnosis of Rectal Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Molecular Diagnosis of Rectal Cancer, Headquarters and Area Served
Table 22. Global Key Players of Molecular Diagnosis of Rectal Cancer, Product and Application
Table 23. Global Key Players of Molecular Diagnosis of Rectal Cancer, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Type (2018-2023)
Table 27. Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Type (2024-2029)
Table 29. Global Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Molecular Diagnosis of Rectal Cancer Revenue Share by Application (2018-2023)
Table 31. Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Molecular Diagnosis of Rectal Cancer Revenue Share by Application (2024-2029)
Table 33. North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Molecular Diagnosis of Rectal Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Molecular Diagnosis of Rectal Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Molecular Diagnosis of Rectal Cancer Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Molecular Diagnosis of Rectal Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Molecular Diagnosis of Rectal Cancer Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 65. Kingmed Company Details
Table 66. Kingmed Business Overview
Table 67. Kingmed Molecular Diagnosis of Rectal Cancer Product
Table 68. Kingmed Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 69. Kingmed Recent Developments
Table 70. Geneis Company Details
Table 71. Geneis Business Overview
Table 72. Geneis Molecular Diagnosis of Rectal Cancer Product
Table 73. Geneis Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 74. Geneis Recent Developments
Table 75. Unitedgene Company Details
Table 76. Unitedgene Business Overview
Table 77. Unitedgene Molecular Diagnosis of Rectal Cancer Product
Table 78. Unitedgene Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 79. Unitedgene Recent Developments
Table 80. Yin Feng Gene Company Details
Table 81. Yin Feng Gene Business Overview
Table 82. Yin Feng Gene Molecular Diagnosis of Rectal Cancer Product
Table 83. Yin Feng Gene Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 84. Yin Feng Gene Recent Developments
Table 85. Inmedi Company Details
Table 86. Inmedi Business Overview
Table 87. Inmedi Molecular Diagnosis of Rectal Cancer Product
Table 88. Inmedi Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 89. Inmedi Recent Developments
Table 90. Amoydx Company Details
Table 91. Amoydx Business Overview
Table 92. Amoydx Molecular Diagnosis of Rectal Cancer Product
Table 93. Amoydx Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 94. Amoydx Recent Developments
Table 95. Genetronhealth Company Details
Table 96. Genetronhealth Business Overview
Table 97. Genetronhealth Molecular Diagnosis of Rectal Cancer Product
Table 98. Genetronhealth Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 99. Genetronhealth Recent Developments
Table 100. Berryoncology Company Details
Table 101. Berryoncology Business Overview
Table 102. Berryoncology Molecular Diagnosis of Rectal Cancer Product
Table 103. Berryoncology Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 104. Berryoncology Recent Developments
Table 105. Topgen Company Details
Table 106. Topgen Business Overview
Table 107. Topgen Molecular Diagnosis of Rectal Cancer Product
Table 108. Topgen Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 109. Topgen Recent Developments
Table 110. Roche Company Details
Table 111. Roche Business Overview
Table 112. Roche Molecular Diagnosis of Rectal Cancer Product
Table 113. Roche Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 114. Roche Recent Developments
Table 115. Qiagen Company Details
Table 116. Qiagen Business Overview
Table 117. Qiagen Molecular Diagnosis of Rectal Cancer Product
Table 118. Qiagen Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 119. Qiagen Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 1. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Molecular Diagnosis of Rectal Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Molecular Diagnosis of Rectal Cancer Market Share by Region (2018-2023)
Table 10. Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Molecular Diagnosis of Rectal Cancer Market Share by Region (2024-2029)
Table 12. Molecular Diagnosis of Rectal Cancer Market Trends
Table 13. Molecular Diagnosis of Rectal Cancer Market Drivers
Table 14. Molecular Diagnosis of Rectal Cancer Market Challenges
Table 15. Molecular Diagnosis of Rectal Cancer Market Restraints
Table 16. Global Molecular Diagnosis of Rectal Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Molecular Diagnosis of Rectal Cancer Revenue Share by Players (2018-2023)
Table 18. Global Top Molecular Diagnosis of Rectal Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Rectal Cancer as of 2022)
Table 19. Global Molecular Diagnosis of Rectal Cancer Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Molecular Diagnosis of Rectal Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Molecular Diagnosis of Rectal Cancer, Headquarters and Area Served
Table 22. Global Key Players of Molecular Diagnosis of Rectal Cancer, Product and Application
Table 23. Global Key Players of Molecular Diagnosis of Rectal Cancer, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Type (2018-2023)
Table 27. Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Type (2024-2029)
Table 29. Global Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Molecular Diagnosis of Rectal Cancer Revenue Share by Application (2018-2023)
Table 31. Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Molecular Diagnosis of Rectal Cancer Revenue Share by Application (2024-2029)
Table 33. North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Molecular Diagnosis of Rectal Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Molecular Diagnosis of Rectal Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Molecular Diagnosis of Rectal Cancer Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Molecular Diagnosis of Rectal Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Molecular Diagnosis of Rectal Cancer Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 65. Kingmed Company Details
Table 66. Kingmed Business Overview
Table 67. Kingmed Molecular Diagnosis of Rectal Cancer Product
Table 68. Kingmed Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 69. Kingmed Recent Developments
Table 70. Geneis Company Details
Table 71. Geneis Business Overview
Table 72. Geneis Molecular Diagnosis of Rectal Cancer Product
Table 73. Geneis Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 74. Geneis Recent Developments
Table 75. Unitedgene Company Details
Table 76. Unitedgene Business Overview
Table 77. Unitedgene Molecular Diagnosis of Rectal Cancer Product
Table 78. Unitedgene Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 79. Unitedgene Recent Developments
Table 80. Yin Feng Gene Company Details
Table 81. Yin Feng Gene Business Overview
Table 82. Yin Feng Gene Molecular Diagnosis of Rectal Cancer Product
Table 83. Yin Feng Gene Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 84. Yin Feng Gene Recent Developments
Table 85. Inmedi Company Details
Table 86. Inmedi Business Overview
Table 87. Inmedi Molecular Diagnosis of Rectal Cancer Product
Table 88. Inmedi Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 89. Inmedi Recent Developments
Table 90. Amoydx Company Details
Table 91. Amoydx Business Overview
Table 92. Amoydx Molecular Diagnosis of Rectal Cancer Product
Table 93. Amoydx Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 94. Amoydx Recent Developments
Table 95. Genetronhealth Company Details
Table 96. Genetronhealth Business Overview
Table 97. Genetronhealth Molecular Diagnosis of Rectal Cancer Product
Table 98. Genetronhealth Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 99. Genetronhealth Recent Developments
Table 100. Berryoncology Company Details
Table 101. Berryoncology Business Overview
Table 102. Berryoncology Molecular Diagnosis of Rectal Cancer Product
Table 103. Berryoncology Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 104. Berryoncology Recent Developments
Table 105. Topgen Company Details
Table 106. Topgen Business Overview
Table 107. Topgen Molecular Diagnosis of Rectal Cancer Product
Table 108. Topgen Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 109. Topgen Recent Developments
Table 110. Roche Company Details
Table 111. Roche Business Overview
Table 112. Roche Molecular Diagnosis of Rectal Cancer Product
Table 113. Roche Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 114. Roche Recent Developments
Table 115. Qiagen Company Details
Table 116. Qiagen Business Overview
Table 117. Qiagen Molecular Diagnosis of Rectal Cancer Product
Table 118. Qiagen Revenue in Molecular Diagnosis of Rectal Cancer Business (2018-2023) & (US$ Million)
Table 119. Qiagen Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Molecular Diagnosis of Rectal Cancer Market Share by Type: 2022 VS 2029
Figure 3. PCR Features
Figure 4. FISH Features
Figure 5. DNA Sequencing Features
Figure 6. Gene Chip Features
Figure 7. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Molecular Diagnosis of Rectal Cancer Market Share by Application: 2022 VS 2029
Figure 9. Clinical Diagnosis Case Studies
Figure 10. Drug Screening Case Studies
Figure 11. Research Case Studies
Figure 12. Molecular Diagnosis of Rectal Cancer Report Years Considered
Figure 13. Global Molecular Diagnosis of Rectal Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Molecular Diagnosis of Rectal Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Molecular Diagnosis of Rectal Cancer Market Share by Region: 2022 VS 2029
Figure 16. Global Molecular Diagnosis of Rectal Cancer Market Share by Players in 2022
Figure 17. Global Top Molecular Diagnosis of Rectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Rectal Cancer as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Molecular Diagnosis of Rectal Cancer Revenue in 2022
Figure 19. North America Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
Figure 21. North America Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
Figure 22. North America Molecular Diagnosis of Rectal Cancer Market Share by Country (2018-2029)
Figure 23. United States Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Molecular Diagnosis of Rectal Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
Figure 27. Europe Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
Figure 28. Europe Molecular Diagnosis of Rectal Cancer Market Share by Country (2018-2029)
Figure 29. Germany Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Molecular Diagnosis of Rectal Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
Figure 37. China Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
Figure 38. Asia Molecular Diagnosis of Rectal Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
Figure 40. Asia Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
Figure 41. Asia Molecular Diagnosis of Rectal Cancer Market Share by Region (2018-2029)
Figure 42. Japan Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Share by Country (2018-2029)
Figure 52. Brazil Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Kingmed Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 59. Geneis Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 60. Unitedgene Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 61. Yin Feng Gene Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 62. Inmedi Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 63. Amoydx Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 64. Genetronhealth Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 65. Berryoncology Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 66. Topgen Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 67. Roche Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 68. Qiagen Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Figure 1. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Molecular Diagnosis of Rectal Cancer Market Share by Type: 2022 VS 2029
Figure 3. PCR Features
Figure 4. FISH Features
Figure 5. DNA Sequencing Features
Figure 6. Gene Chip Features
Figure 7. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Molecular Diagnosis of Rectal Cancer Market Share by Application: 2022 VS 2029
Figure 9. Clinical Diagnosis Case Studies
Figure 10. Drug Screening Case Studies
Figure 11. Research Case Studies
Figure 12. Molecular Diagnosis of Rectal Cancer Report Years Considered
Figure 13. Global Molecular Diagnosis of Rectal Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Molecular Diagnosis of Rectal Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Molecular Diagnosis of Rectal Cancer Market Share by Region: 2022 VS 2029
Figure 16. Global Molecular Diagnosis of Rectal Cancer Market Share by Players in 2022
Figure 17. Global Top Molecular Diagnosis of Rectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Rectal Cancer as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Molecular Diagnosis of Rectal Cancer Revenue in 2022
Figure 19. North America Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
Figure 21. North America Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
Figure 22. North America Molecular Diagnosis of Rectal Cancer Market Share by Country (2018-2029)
Figure 23. United States Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Molecular Diagnosis of Rectal Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
Figure 27. Europe Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
Figure 28. Europe Molecular Diagnosis of Rectal Cancer Market Share by Country (2018-2029)
Figure 29. Germany Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Molecular Diagnosis of Rectal Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
Figure 37. China Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
Figure 38. Asia Molecular Diagnosis of Rectal Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
Figure 40. Asia Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
Figure 41. Asia Molecular Diagnosis of Rectal Cancer Market Share by Region (2018-2029)
Figure 42. Japan Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Molecular Diagnosis of Rectal Cancer Market Share by Country (2018-2029)
Figure 52. Brazil Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Kingmed Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 59. Geneis Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 60. Unitedgene Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 61. Yin Feng Gene Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 62. Inmedi Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 63. Amoydx Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 64. Genetronhealth Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 65. Berryoncology Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 66. Topgen Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 67. Roche Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 68. Qiagen Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
